The mechanism of Gejie Zhilao Pill in treating tuberculosis based on network pharmacology and molecular docking verification
Frontiers in Cellular and Infection Microbiology · 2024
DOI: 10.3389/fcimb.2024.1405627 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2024. Verfasst von Yuhui Gao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Emergency Department, The Second Affiliated Hospital, Dalian Medical University, Dalian, Liaoning, China. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Drugs, Chinese Herbal, Network Pharmacology. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Gejie Zhilao Pill (GJZLP), a traditional Chinese medicine formula is known for its unique therapeutic effects in treating pulmonary tuberculosis. The aim of this study is to further investigate its underlying mechanisms by utilizing network pharmacology and molecular docking techniques.
Methods
Using TCMSP database the components, potential targets of GJZLP were identified. Animal-derived components were supplemented through the TCMID and BATMAN-TCM databases. Tuberculosis-related targets were collected from the TTD, OMIM, and GeneCards databases. The intersection target was imported into the String database to build the PPI network. The Metascape platform was employed to carry out Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis. Heatmaps were generated through an online platform ( https://www.bioinformatics.com.cn ). Molecular docking was conducted between the core targets and core compounds to explore their binding strengths and patterns at the molecular level.
Results
61 active ingredients and 118 therapeutic targets were identified. Quercetin, Luteolin, epigallocatechin gallate, and beta-sitosterol showed relatively high degrees in the network. IL6, TNF, JUN, TP53, IL1B, STAT3, AKT1, RELA, IFNG, and MAPK3 are important core targets. GO and KEGG revealed that the effects of GJZLP on tuberculosis mainly involve reactions to bacterial molecules, lipopolysaccharides, and cytokine stimulation. Key signaling pathways include TNF, IL-17, Toll-like receptor and C-type lectin receptor signaling. Molecular docking analysis demonstrated a robust binding affinity between the core compounds and the core proteins. Stigmasterol exhibited the lowest binding energy with AKT1, indicating the most stable binding interaction.
Discussion
This study has delved into the efficacious components and molecular mechanisms of GJZLP in treating tuberculosis, thereby highlighting its potential as a promising therapeutic candidate for the treatment of tuberculosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Emergency Department, The Second Affiliated Hospital, Dalian Medical University, Dalian, Liaoning, China.
- Research and Teaching Department of Comparative Medicine, Dalian Medical University, Dalian, Liaoning, China.
Zitieren
APA
Gao, Y., Shang, B., He, Y., Deng, W., Wang, L., & Sui, S. (2024). The mechanism of Gejie Zhilao Pill in treating tuberculosis based on network pharmacology and molecular docking verification. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1405627
Vancouver
Gao Y, Shang B, He Y, Deng W, Wang L, Sui S. The mechanism of Gejie Zhilao Pill in treating tuberculosis based on network pharmacology and molecular docking verification. Frontiers in Cellular and Infection Microbiology. 2024. doi:10.3389/fcimb.2024.1405627
BibTeX
@article{Gao2024,
author = {Gao, Yuhui and Shang, Bingbing and He, Yanyao and Deng, Wen and Wang, Liang and Sui, Shaoguang},
title = {The mechanism of Gejie Zhilao Pill in treating tuberculosis based on network pharmacology and molecular docking verification},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2024},
doi = {10.3389/fcimb.2024.1405627}
}
EUVIMED